Jean Wagnon

This inventor holds 33 USPTO granted patents and 5 published patent applications and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi, Sanofi-Aventis, Sanofi-Synthelabo. Active years: 1983-2010.

USPTO Granted Patents = 33 (Patent Applications = 5)

% Patents Active = 72.7

EPO Patents = 3

Average Co-Inventor Count = 4.0

ph-index = 13

Forward Citations = 469(Granted Patents)

Location History:

Montpellier, FR (1983 - 2010)
Antony, FR (2010)

Company Filing History:

National Institute of Health and Medical Research

Societe Anonyme Dite : Sanofi

patents

9. 1 out of 8

Societe Anonyme Sanofi

patents

10. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1983-2010

Loading Chart...

Areas of Expertise:

Indolizine Derivatives

Piperidine Derivatives

Peptide Inhibitors

Therapeutic Compositions

Pharmaceutical Applications

Indole Derivatives

Renin Inhibitors

Cardiovascular Compositions

Stereospecific Synthesis

Acyloxypyrrolidine Derivatives

Phenylsulfonyl Derivatives

Piperazinylacylpiperidine

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7799799 - Indolizine derivatives, method for preparing same, and therapeutic compositions comprising same (2010-09-21),

2. 7652011 - 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application (2010-01-26),

3. 7468368 - Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof (2008-12-23),

4. 7425566 - 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them (2008-09-16),

5. 7423039 - (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics (2008-09-09),

6. 7297692 - [object Object] (2007-11-20),

7. 7294628 - Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof (2007-11-13),

8. 7202267 - Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic (2007-04-10),

9. 7129240 - 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them (2006-10-31),

10. 7119086 - Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use (2006-10-10),

11. 6864277 - 1,3-dihydro-2H-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them (2005-03-08),

12. 6730695 - 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors (2004-05-04),

13. 6624164 - 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them (2003-09-23),

14. 6596732 - 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same (2003-07-22),

15. 5849780 - 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their (1998-12-15),

Title: Jean Wagnon - Innovative Inventor from Montpellier

Introduction: Jean Wagnon is a renowned inventor hailing from the vibrant city of Montpellier, France. With a passion for creativity and problem-solving, he has made significant contributions to the field of innovation.

Latest Patents: Jean Wagnon holds several patents in various industries, including technology, healthcare, and sustainable energy. His recent patents focus on cutting-edge solutions for environmental challenges and advancements in digital communication.

Career Highlights: Throughout his career, Jean Wagnon has been recognized for his groundbreaking inventions that have revolutionized the way we live and work. His dedication to pushing the boundaries of innovation has led to numerous awards and accolades.

Collaborations: Jean Wagnon has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines and industries has resulted in successful partnerships that have furthered the impact of his work.

Conclusion: Jean Wagnon's innovative spirit and commitment to creating a better future through his inventions make him a standout figure in the world of innovation. His contributions continue to inspire the next generation of inventors and shape the landscape of technological advancement.